Fuji Pharma Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3816200004
JPY
2,276.00
50 (2.25%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
15,897.00
14,723.00
12,859.00
11,095.00
13,000.00
12,983.00
11,767.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
15,897.00
14,723.00
12,859.00
11,095.00
13,000.00
12,983.00
11,767.00
Raw Material Cost
9,078.00
8,712.00
7,997.00
6,510.00
7,785.00
7,737.00
7,573.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
84.00
93.00
95.00
66.00
76.00
59.00
54.00
Selling and Distribution Expenses
3,211.00
3,154.00
3,054.00
2,915.00
3,216.00
2,681.00
2,648.00
Other Expenses
73.70
114.10
65.20
55.20
66.90
84.20
72.00
Total Expenditure (Excl Depreciation)
13,110.00
13,100.00
11,798.00
10,043.00
11,746.00
11,319.00
10,995.00
Operating Profit (PBDIT) excl Other Income
2787
1623
1061
1052
1254
1664
772
Other Income
-5.00
21.00
-24.00
34.00
48.00
4.00
52.00
Operating Profit (PBDIT)
3,785.00
2,653.00
2,003.00
2,065.00
2,313.00
2,654.00
1,805.00
Interest
84.00
93.00
95.00
66.00
76.00
59.00
54.00
Exceptional Items
-2,501.00
-250.00
6.00
-640.00
147.00
-155.00
22.00
Gross Profit (PBDT)
6,819.00
6,011.00
4,862.00
4,585.00
5,215.00
5,246.00
4,194.00
Depreciation
1,003.00
1,009.00
966.00
979.00
1,011.00
986.00
981.00
Profit Before Tax
196.00
1,301.00
948.00
379.00
1,372.00
1,457.00
792.00
Tax
-128.00
132.00
404.00
83.00
381.00
219.00
139.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
324.00
1,170.00
543.00
296.00
991.00
1,237.00
653.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
324.00
1,170.00
543.00
296.00
991.00
1,237.00
653.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
324.00
1,170.00
543.00
296.00
991.00
1,237.00
653.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
47,948.00
46,905.00
45,524.00
45,731.00
47,756.00
45,560.00
44,957.00
Earnings per share (EPS)
13.25
47.84
22.23
12.12
40.74
50.84
26.86
Diluted Earnings per share
13.25
47.84
22.23
12.12
40.74
50.84
26.86
Operating Profit Margin (Excl OI)
17.53%
11.02%
8.25%
9.48%
9.65%
12.82%
6.56%
Gross Profit Margin
7.54%
15.69%
14.88%
12.24%
18.33%
18.82%
15.07%
PAT Margin
2.04%
7.95%
4.22%
2.67%
7.62%
9.53%
5.55%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 7.97% vs 14.50% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is -72.31% vs 115.47% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 44.00% vs 29.85% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is -9.68% vs -2.11% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Fuji Pharma Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
15,897.00
12,130.00
3,767.00
31.06%
Other Operating Income
0.00
0.00
0.00
Total Operating income
15,897.00
12,130.00
3,767.00
31.06%
Raw Material Cost
9,078.00
9,923.00
-845.00
-8.52%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
84.00
33.00
51.00
154.55%
Selling and Distribution Expenses
3,211.00
1,580.00
1,631.00
103.23%
Other Expenses
73.70
-3.30
77.00
2,333.33%
Total Expenditure (Excl Depreciation)
13,110.00
11,503.00
1,607.00
13.97%
Operating Profit (PBDIT) excl Other Income
2,787.00
627.00
2,160.00
344.50%
Other Income
-5.00
182.00
-187.00
-102.75%
Operating Profit (PBDIT)
3,785.00
1,897.00
1,888.00
99.53%
Interest
84.00
33.00
51.00
154.55%
Exceptional Items
-2,501.00
2.00
-2,503.00
-125,150.00%
Gross Profit (PBDT)
6,819.00
2,207.00
4,612.00
208.97%
Depreciation
1,003.00
1,088.00
-85.00
-7.81%
Profit Before Tax
196.00
780.00
-584.00
-74.87%
Tax
-128.00
236.00
-364.00
-154.24%
Provisions and contingencies
0
0
0.00
Profit After Tax
324.00
536.00
-212.00
-39.55%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
324.00
536.00
-212.00
-39.55%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
8.00
-8.00
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
324.00
544.00
-220.00
-40.44%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
47,948.00
52,168.00
-4,220.00
-8.09%
Earnings per share (EPS)
13.25
18.11
-4.86
-26.84%
Diluted Earnings per share
13.25
18.11
-4.86
-26.84%
Operating Profit Margin (Excl OI)
17.53%
5.17%
0.00
12.36%
Gross Profit Margin
7.54%
15.40%
0.00
-7.86%
PAT Margin
2.04%
4.42%
0.00
-2.38%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,589.70 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 7.97% vs 14.50% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 22.28% vs 20.98% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 32.40 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -72.31% vs 115.47% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -67.31% vs -63.82% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 379.00 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 44.00% vs 29.85% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 67.33% vs 221.28% in Dec 2024

Quarterly - Interest
Interest 8.40 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -9.68% vs -2.11% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 10.53% vs 90.00% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.53%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024